Product Information
Name:BCI-121
Brand:Biosynth
Description:BCI-121 is an investigational drug that inhibits the enzyme lysine methyltransferase (KMT), which is involved in the methylation of histones and other cellular proteins. BCI-121 has been shown to inhibit tumor growth and induce tumor cell death by inhibiting mitochondrial functions. The mechanism of action for BCI-121 involves epigenetic regulation of gene expression, meaning that it controls the activity of genes without altering their DNA sequence. In cancer cells, BCI-121 inhibits the synthesis of DNA, RNA, and protein, leading to apoptosis. This drug also shows potential for treating inflammatory diseases such as rheumatoid arthritis by inhibiting KMT activity in immune cells.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:340.22 g/mol
Formula:C14H18BrN3O2
Purity:Min. 95%
Technical inquiry about: BCI-121
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.